Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Are there protein amyloids in cancer?

A postgraduate research opportunity at the University of Otago.

Details

Close date
Thursday, 22 December 2022
Academic background
Health Sciences
Host campus
Christchurch
Qualification
PhD
Department
Pathology and Biomedical Science (Christchurch)
Supervisor
Dr Christoph Goebl

Overview

PhD candidates are being recruited to join the team at the Centre of Free Radical Research, University of Otago, Christchurch.

At the Centre for Free Radical Research you will complete your postgraduate study while working alongside other students and experienced scientists from all over the world.

We recently discovered that one of the most frequently mutated proteins in cancer, the tumour suppressor protein p16, can form amyloid structures upon oxidation (1). Amyloid protein structures are frequently found in neurodegenerative diseases such as Alzheimer’s disease (a-beta) or Parkinson’s disease (alpha-synuclein).

In this project, we aim to spearhead the investigation of amyloids in cancer. Amyloid p16 seems to be non-functional and might therefore contribute to tumour development.

This PhD fellowship will enable the candidate to study p16 amyloids in great detail, including mechanistic and structural studies of molecular changes, computational modelling, cell biological and tumour analysis and method development for future diagnostic applications. The specific focus will depend on the interest of the candidate.

This project involves collaborations with international research groups located in the USA, Canada, Germany, Austria and Australia and we will consider a research stay with one of our partners during course of the studies.

We welcome students from various backgrounds including biology, medicine, engineering or others. You will join a young and enthusiastic international team of cancer researchers. If you think that certain aspects of this project sound interesting to you, don’t hesitate to contact us for more information.

(1) Cysteine oxidation triggers amyloid fibril formation of the tumor suppressor p16INK4A
Göbl C., Morris V.K. et al., Redox Biology 2020, 28,101316

Applicants must be eligible for admission to the PhD programme at the University of Otago. View entry requirements.

Funding Notes:

This 3 year project is fully funded by a Marsden Project Grant. It covers subscription fees and a yearly stipend of NZ$35,000.

Application:

In the first instance, applicants should contact Dr Christoph Goebl by email to discuss the project. Further information may be sought from suitable candidates that will include:

  • a copy of your CV
  • a copy of your academic transcript
  • a pdf copy of your research thesis

Further Information:

The Department of Pathology and Biomedical Science has a number of potential topics and projects on offer in the fields of biomedical science and pathology for a range of postgraduate qualifications, including PhD and BBiomedSc(Hons).

We welcome enquiries and encourage all prospective students to directly contact potential supervisors in their field of interest.

Contact

Dr Christoph Goebl
Tel   +64 3 364 1559
Email   christoph.goebl@otago.ac.nz